What does this Advisor Specialize in? Find a financial advisor who specializes in the area of expertise you require. It's important to find an advisor who can help you approach your personal and ...

What does this Advisor Specialize in? Find a financial advisor who specializes in the area of expertise you require. It's important to find an advisor who can help you approach your personal and ...

ST. LOUIS, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported selected operating results for January 31, 2025 in an effort to provide timely information to investors on ...

Company Information Stifel Financial Corp. (NYSE: SF) is a financial services holding company headquartered in St. Louis ... United States through Stifel, Nicolaus & Company, Incorporated ...

ST. LOUIS — Kristen Taylor, managing director/investments with Stifel Financial Corp. in Wenatchee, a Stifel, Nicolaus & Company, Incorporated broker-dealer subsidiary, was named on Forbes’ 2025 ...

In this episode, host Mike Miller chats with Stifel CEO Ron Kruszewski. The discussion touches on Kruszewski’s optimism about the future of downtown St. Louis, including why he believes it’s important ...

ST. LOUIS — Grammy Award-winning ... Tour," which includes two performances in St. Louis Simon will perform April 28-29 at Stifel Theatre alongside his band: Caleb Burhans (viola), Jamey Haddad ...

Subscribe to the St. Louis Business newsletter to get the latest insights sent to your inbox every morning. We will never send spam or annoying emails. Unsubscribe anytime. Since Ron Kruszewski took ...

In a report released yesterday, Chris O`Cull from Stifel Nicolaus maintained a Hold rating on Wendy’s (WEN – Research Report), with a price target of $16.00. The company’s shares closed last ...

Stifel Nicolaus analyst J. Parker Lane maintained a Buy rating on Guidewire (GWRE – Research Report) today and set a price target of $230.00. See what stocks are receiving Strong Buy ratings ...

Shares of CRWD opened at $333.50 on Wednesday. The firm has a market cap of $82.14 billion, a P/E ratio of 653.93, a price-to-earnings-growth ratio of 17.86 and a beta of 1.19. CrowdStrike has a ...

Shares of AbCellera Biologics stock opened at $2.59 on Friday. AbCellera Biologics has a 1 year low of $2.31 and a 1 year high of $5.26. The company has a market capitalization of $765.00 million ...